UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS.
Holly H BlackJessica L HansonJulia E RobertsShannon N LeslieWilliam Campodonico-BurnettChristopher C EbmeierG Aaron HollingJian Wei TayAutumn M MatthewsElizabeth UngCristina I LauAlexandra M WhiteleyPublished in: eLife (2023)
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron dysfunction and loss. A portion of ALS cases are caused by mutation of the proteasome shuttle factor Ubiquilin 2 ( UBQLN2 ), but the molecular pathway leading from UBQLN2 dysfunction to disease remains unclear. Here, we demonstrate that UBQLN2 regulates the domesticated gag-pol retrotransposon 'paternally expressed gene 10' (PEG10) in human cells and tissues. In cells, the PEG10 gag-pol protein cleaves itself in a mechanism reminiscent of retrotransposon self-processing to generate a liberated 'nucleocapsid' fragment, which uniquely localizes to the nucleus and changes the expression of genes involved in axon remodeling. In spinal cord tissue from ALS patients, PEG10 gag-pol is elevated compared to healthy controls. These findings implicate the retrotransposon-like activity of PEG10 as a contributing mechanism in ALS through regulation of gene expression, and restraint of PEG10 as a primary function of UBQLN2.
Keyphrases
- amyotrophic lateral sclerosis
- drug delivery
- gene expression
- spinal cord
- healthcare
- oxidative stress
- public health
- end stage renal disease
- dna methylation
- multiple sclerosis
- poor prognosis
- mental health
- spinal cord injury
- prognostic factors
- patient reported outcomes
- single molecule
- patient reported
- respiratory syndrome coronavirus
- endoplasmic reticulum stress
- optic nerve